-
Ensuring Patient Inclusion When Baseline Is Missing: Utilizing Constrained Longitudinal Data Analysis (cLDA) for Patient-Reported Outcomes (PROs)
Sep 9, 2025, 16:22 PM -
An Economic Evaluation of Risankizumab vs. Adalimumab in Moderate to Severe Plaque Psoriasis Adult Patients in Egypt
Sep 9, 2025, 16:22 PM -
Germany: Still a Benchmark for ATMP Access and Pricing: A Pricing Analysis of Germany's ATMP Landscape Compared to Other European Countries
Sep 9, 2025, 16:22 PM -
Patient Pathways to Accessing Unregistered Medicines in Low-Priority Launch Markets
Sep 9, 2025, 16:22 PM -
Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Prediction of Query Outcomes in the Setting of Observational Studies
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of High-Energy High-Protein (HEHP) Oral Nutritional Support (ONS) for the Treatment of Disease-Related Malnutrition (DRM) in Cancer Patients in the French Community Setting
Sep 9, 2025, 16:22 PM -
Economic Burden of Systemic Lupus Erythematosus (SLE) Among Women in the USA: A Systematic Review
Sep 9, 2025, 16:22 PM -
Comparative Cardiovascular Safety of Romosozumab and Denosumab in Osteoporosis Treatment: A Multinational Real-World Cohort Study
Sep 9, 2025, 16:22 PM -
Air Pollution Signals and National Demand for Asthma Medication in Brazil Between 2018-2023: Should It Be Considered a Public-Health Concern?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Evaluation of RSVpreF Vaccine for Preventing RSV Among Older Adults With High Risk Under Taiwan National Vaccination Program
Sep 9, 2025, 16:22 PM -
Cost of First-Line Treatment of Hepatocellular Carcinoma With the Immune Checkpoint Inhibitor-Based Regimens STRIDE and Atezolizumab Plus Bevacizumab in Brazil
Sep 9, 2025, 16:22 PM -
Tracing the Shift in Payer Evidence Expectations: A Review of AMCP Format Updates (2016-2024)
Sep 9, 2025, 16:22 PM -
Evaluating GenAI for HTA Analogue Analysis: Identifying Rare Disease Approvals With Surrogate Endpoints and Single-Arm Trials
Sep 9, 2025, 16:22 PM -
Understanding Heterogeneity in the Classification of Locally Advanced Cancer: Analysis of Clinical Trial Records From the Past 2 Years (2023-2025)
Sep 9, 2025, 16:22 PM -
Development of a Discrete Choice Experiment Survey to Assess Patient Preferences for Treatment of Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Stop Ignoring Missing Patients the Hidden Impact of Ignoring Missing Data in Health State Utility Estimation
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Epigenetic Drugs in Oncology: A Systematic Review of Economic Evaluations
Sep 9, 2025, 16:22 PM -
Use of Encorafenib + Cetuximab EC in Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer (mCRC) in Real-World Settings: Data Visualization From a Pooled Dataset of European Observational Studies
Sep 9, 2025, 16:22 PM -
Real-World Patient Characteristics and Outcomes Associated With Antibody Drug Conjugate Therapy: A Large Cohort Study
Sep 9, 2025, 16:22 PM
